Insights from AUA 2024 Annual Meeting
AUA 2024 Insights: "MoonRISe-1 Study - Erdafitinib-Releasing Intravesical Delivery System (TAR-210) vs. Intravesical Chemo in Intermediate-Risk NMIBC With FGFR Alterations"
By
Insights from AUA 2024 Annual Meeting
FEATURING
Roger Li
By
Insights from AUA 2024 Annual Meeting
FEATURING
Roger Li
Login to view comments.
Click here to Login
Videos